Australia’s active vaccine safety system

Mpox vaccine safety surveillance conducted by AusVaxSafety was completed on 17 April 2023. Data on this page will no longer be updated. Safety data collected from more than 15,000 JYNNEOS mpox vaccine recipients identified no safety issues in either administration method, intradermal and subcutaneous.

The Therapeutic Goods Administration (TGA) continues to monitor the safety of mpox vaccines in Australia.


Mpox vaccine safety data

Click on the tiles below to view subcutaneous and intradermal mpox vaccine safety data.